New Delhi: India's top drug regulator-- Drugs Controller General of India has granted permission to Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said. And after considering the data generated on the vaccine in phase-1, 2 of the Oxford University trial, the committee recommended …
